To further identify podocyte-related biomarkers in DKD, we conducted a comprehensive analysis and screening and found that ARHGEF26 was downregulated in both the glomeruli and podocytes, emphasizing its potential role in DKD progression. Here, ARHGEF26 is linked to diabetic kidney disease.